Evidence map›Paper›PMID 41224296›Full record

ArticleBMJ open2025

Development of a case definition for polycystic ovary syndrome using administrative health data: a validation study.

Jenna N Salem, Robyn Vettese, Jennifer M Yamamoto, Sheffinea Koshy, Tyrone Harrison, Nikki Stephenson, Paul E Ronksley, Amy Metcalfe, Erin A Brennand, Jamie L Benham

Abstract readValidation Study
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jenna N SalemDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Robyn VetteseDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Jennifer M YamamotoDepartment of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID http://orcid.org/0000-0002-3556-0820
Sheffinea KoshyDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Tyrone HarrisonDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID http://orcid.org/0000-0003-1068-8673
Nikki StephensonDepartment of Obstetrics and Gynaecology, University of Calgary, Calgary, Alberta, Canada.
Paul E RonksleyDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Amy MetcalfeDepartment of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Erin A BrennandO'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
Jamie L BenhamDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada jlbenham@ucalgary.ca.ORCID http://orcid.org/0000-0002-2233-4613

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo develop and validate a polycystic ovary syndrome (PCOS) case definition using administrative health data sources.

designA validation study.

settingSecondary care centre outpatient gynaecology clinic in Calgary, Alberta, Canada.

participants3951 electronic health records of women aged 18-45 years who presented to a gynaecology clinic in Calgary, Canada, between January 2014 and December 2019 were reviewed. We identified 180 patients with PCOS using the Rotterdam criteria. Participants were excluded if they were biologically male, pregnant at the time of the consultation, did not meet the date criteria or if their consultation note was missing. The chart data were connected to the Practitioner Claims and the Discharge Abstract Database by personal health number. PRIMARY AND SECONDARY OUTCOME MEASURES: Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of 68 case definitions for PCOS were estimated. Case definition performance was graded.

resultsOf the 68 case definitions tested, none had high validity. The best performing case definitions were: (1) ≥3 instances of International Classification of Diseases-9 code 256.4 (polycystic ovaries) with exclusion codes (sensitivity 23.89%, specificity 99.59%, PPV 74.14%, NPV 96.35%) and (2) 626.X (irregular menstruation), 704.1 (hirsutism) and ≥3 instances of code 256.4 with exclusion codes (sensitivity 2.78%, specificity 99.97%, PPV 83.33%, NPV 95.40%).

conclusionsWe identified several case definitions for PCOS of moderate validity with high PPV (>70%) for case ascertainment in PCOS research in jurisdictions with similar administrative health data. These case definitions are limited by low sensitivity, which should be considered when interpreting research findings.

Indexed as

Electronic Health RecordsPolycystic Ovary SyndromeAdolescentAdultAlbertaFemaleHumansInternational Classification of DiseasesMiddle AgedPredictive Value of TestsReproducibility of ResultsSensitivity and SpecificityYoung AdultChronic DiseaseGeneral endocrinologyREPRODUCTIVE MEDICINESensitivity and Specificity

Identifiers

PMID41224296
PMCPMC12658500

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.